ArticleMedicine2025
Co-occurrence of acute hemolytic anemia and methemoglobinemia in a 74-year-old female with G6PD deficiency: A case report.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleAcute hemolysis and methemoglobinemia rarely coexist in patients with glucose-6-phosphate dehydrogenase (G6PD)-deficient disease. Methylene blue is widely recognized as the first-line treatment for methemoglobinemia; however, it can worsen hemolysis owing to its oxidative effects in patients with G6PD deficiency. PATIENT CONCERNS: A rare case of acute hemolytic anemia and methemoglobinemia induced by ingestion of fresh raw fava beans in a 74-year-old female with G6PD deficiency was reported in this paper. DIAGNOSES: Laboratory test results revealed anemia (low hemoglobin level of 81 g/L) with evidence of hemolysis (high reticulocyte count 11.93%, high indirect bilirubin 155.7 μmol/L, high proportion of poikilocytes [16.5%] observed in peripheral blood smears). Arterial blood gas analysis showed a high methemoglobin level (7.3%). Detection of mutations in G6PD confirmed the diagnosis of G6PD deficiency.
interventionsThe administration of methylene blue exacerbated the hemolysis of this patient, resulting in a sustained decrease in hemoglobin levels from 81 to 38 g/L. Methylene blue treatment was replaced by vitamin C and methylprednisolone upon diagnosis of G6PD deficiency. OUTCOMES: The clinical symptoms of this patient were gradually improved after vitamin C and methylprednisolone treatment, and 1 month after discharge, the hemoglobin level recovered to within the normal range. LESSONS: Our case highlights the importance of evaluating G6PD deficiency as soon as the patient is first diagnosed with methemoglobinemia. Although acute hemolytic anemia and methemoglobinemia rarely co-occur in elderly patients with G6PD deficiency, care should be taken with methylene blue, which can worsen hemolysis. The fava bean plays an important role in the hemolytic crisis. Therefore, it is crucial to identify the cause of oxidative stress and its co-occurrence to prevent further oxidative stress-induced hemolysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.